5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 4.84▲ | 4.84▲ | 4.84▲ | 4.62▲ | 4.19▲ |
MA10 | 4.83▲ | 4.85▼ | 4.89▼ | 4.37▲ | 3.66▲ |
MA20 | 4.84▲ | 4.88▼ | 4.81▲ | 4.03▲ | 3.22▲ |
MA50 | 4.85▼ | 4.67▲ | 4.47▲ | 3.47▲ | 2.85▲ |
MA100 | 4.88▼ | 4.45▲ | 4.25▲ | 3.09▲ | 2.44▲ |
MA200 | 4.76▲ | 4.17▲ | 3.80▲ | 2.93▲ | 1.85▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.004▲ | -0.023▼ | -0.023▼ | 0.075▲ | 0.188▲ |
RSI | 52.144▲ | 53.858▲ | 60.289▲ | 70.916▲ | 80.399▲ |
STOCH | 63.280 | 26.744 | 26.206 | 75.786 | 81.179▲ |
WILL %R | -29.412 | -77.778▼ | -63.636 | -17.778▲ | -10.345▲ |
CCI | 140.881▲ | -57.851 | -19.800 | 179.799▲ | 187.002▲ |
Thursday, August 14, 2025 01:22 PM
Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor ...
|
Wednesday, August 13, 2025 01:44 PM
Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK-pathway-driven cancers, today announced positive, updated safety and ...
|
Wednesday, August 13, 2025 06:23 AM
Qudian Inc. ("Qudian" or "the Company" or "We") (NYSE: QD), a consumer-oriented technology company in China, today ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
19/08/25 | 5.08 | 5.08 | 4.78 | 4.84 | 854,900 |
18/08/25 | 4.65 | 5.08 | 4.6287 | 5.02 | 1,413,755 |
15/08/25 | 4.26 | 4.729 | 4.26 | 4.67 | 946,396 |
14/08/25 | 4.30 | 4.3128 | 4.175 | 4.24 | 446,503 |
13/08/25 | 4.19 | 4.535 | 4.165 | 4.32 | 1,009,541 |
12/08/25 | 4.15 | 4.19 | 4.085 | 4.10 | 94,639 |
11/08/25 | 4.15 | 4.1962 | 4.06 | 4.15 | 113,817 |
08/08/25 | 4.11 | 4.295 | 4.08 | 4.21 | 624,495 |
07/08/25 | 4.02 | 4.13 | 3.9237 | 4.10 | 362,159 |
06/08/25 | 3.93 | 4.10 | 3.8302 | 4.04 | 332,925 |
|
|
||||
|
|
||||
|
|